Table 4 Adverse events after intervention.
Characteristics | Vitamin C Group (n = 70) | Placebo Group (n = 71) |
|---|---|---|
Withdrawal from trial for adverse events, n (%) | 0 (0) | 0 (0) |
Patients with ≥ 1 adverse events 2 hours after trial, n (%) | 16 (22.9) | 11 (15.4) |
Patients with ≥ 1 adverse events 1 day after trial, n (%) | 4 (5.7) | 4 (5.6) |
Total adverse events, n | 24 | 17 |
Patients who experienced specific adverse events 2 hours after intervention, n (%) | Â | |
itching sense/pain at injection site | 9 (12.9) | 8 (11.3) |
dry mouth | 7 (10) | 2 (2.8) |
others* | 4 (5.7) | 3 (4.2) |
Patients who experienced specific adverse events 1 day after intervention, n (%) | Â | |
itching sense/pain at injection site | 1 (1.4) | 3 (4.2) |
dry mouth | 1 (1.4) | 0 (0) |
diarrhea | 1 (1.4) | 0 (0) |
common cold symptoms | 1 (1.4) | 1 (1.4) |